Skip to main content
NCBI home page
International Journal of Cardiology Congenital Heart Disease logoLink to International Journal of Cardiology Congenital Heart Disease
. 2023 Nov 18;14:100474. doi: 10.1016/j.ijcchd.2023.100474

Corrigendum to ‘The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease’, Int. J. Cardiol. Congenit. Heart Dis., 8, June 2022, 100384☆

Laith Alshawabkeh a,b,c,∗, Nicole L Herrick a, Alexander R Opotowsky b,c,d, Tajinder P Singh c, Michael Landzberg b,c, Marcus A Urey a, Wida Cherikh e, Joseph W Rossano f, Michael M Givertz b
PMCID: PMC11658201  PMID: 39712990

The authors regret that the Disclosure statement originally published with the article included the incorrect journal name. The corrected Disclosure statement reads as follows.

The authors would like to apologise for any inconvenience caused.

Footnotes

☆

Dr. Rossano has conflicts of interest to disclose as described by the International Journal of Cardiology Congenital Heart Disease: he reports personal fees from Amgen, personal fees from Novartis, personal fees from Bayer, personal fees from Abiomed, outside the submitted work. Other authors have no conflicts of interest to disclose as described by the International Journal of Cardiology Congenital Heart Disease.

Articles from International Journal of Cardiology Congenital Heart Disease are provided here courtesy of Elsevier

RESOURCES